A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Exscientia AI Limited
AstraZeneca
Varian, a Siemens Healthineers Company
UMC Utrecht
University of California, Irvine
Duke University
Grey Wolf Therapeutics
University of Nebraska
Takeda
Natera, Inc.
Second Life Therapeutics
Elephas
Elephas
RenJi Hospital
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Washington University School of Medicine
Delfi Diagnostics Inc.
Milton S. Hershey Medical Center
Brigham and Women's Hospital
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Columbia University
Tempus AI
Tvardi Therapeutics, Incorporated
Intensity Therapeutics, Inc.
Assistance Publique Hopitaux De Marseille
Universidade Federal de Pernambuco
Taproot Health
Zhujiang Hospital
University of Sydney
NantBioScience, Inc.
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Comprehensive Support Project for Oncology Research
Beijing Friendship Hospital
Pfizer
Celldex Therapeutics
IHU Strasbourg
Fusion Pharmaceuticals Inc.
Massachusetts General Hospital
Klus Pharma Inc.
Celldex Therapeutics
Shanghai Yunying Medical Technology
Xencor, Inc.
Quadriga Biosciences, Inc.